|
|
||||||||
Neurology and Research Services, Memphis Veterans Administration Medical Center, and the Department of Neurology, University of Tennessee Center for the Health Sciences, Memphis, TN.
Material cross-reactive with myelin basic protein (BP) peptide 4388 has been identified as a major BP-like antigen appearing in human cerebrospinal fluid during acute myelin injury. In an effort to develop a means for detecting this material in the more accessible body fluids of blood and urine, as well as to determine its metabolic fate, the manner in which rabbits handle human BP peptide 4388 was investigated. Unlabeled peptide was administered intravenously, and its concentration in plasma was monitored by radioimmunoassay. In studies of 10 rabbits, the peptide disappeared from blood in two phases, the first showing a half-life of 6.0 ± 1.2 minutes and the second a half-life of 51.6 ± 5.4 minutes. Organ-exclusion experiments indicated a rapid clearance, predominantly by the kidney, for the peptide, with tubular reabsorption and cleavage into smaller peptide fragments a probable catabolic mechanism.
Address correspondence and reprint requests to Dr. Whitaker, Neurology Service, Memphis Veterans Administration Medical Center, 1030 Jefferson Avenue, Memphis, TN 38104.
Accepted for publication January 9, 1980.
This work was supported by the Medical Research Service of the Veterans Administration and by Grant No. 1111-A-3 from the National Multiple Sclerosis Society. Dr. Bashir is an Associate Investigator and Dr. Whitaker a Medical Investigator of the Veterans Administration.
This article has been cited by other articles:
![]() |
J. N Whitaker Myelin basic protein in cerebrospinal fluid and other body fluids Multiple Sclerosis, February 1, 1998; 4(1): 16 - 21. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |